Sale!

CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test” is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the CCNO gene, which are associated with Primary Ciliary Dyskinesia (PCD) Type 29. PCD is a rare genetic disorder that affects the cilia, leading to respiratory system abnormalities, fertility issues, and other complications. The CCNO gene plays a crucial role in the development and function of cilia, and mutations in this gene can disrupt ciliary function, resulting in the symptoms observed in PCD.

This test is critical for individuals suspected of having PCD Type 29 based on clinical symptoms or family history, as an accurate diagnosis can guide treatment and management decisions. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the CCNO gene.

The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing services, patients can expect a high standard of accuracy and reliability in their test results, which are essential for diagnosing this complex condition and potentially guiding family planning decisions for affected individuals or families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test

At DNA Labs UAE, we offer the CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test. This test is designed to identify mutations in the CCNO gene, which is associated with a rare genetic disorder called primary ciliary dyskinesia type 29.

Primary ciliary dyskinesia (PCD) is a heterogeneous group of genetic disorders characterized by impaired function of cilia in various organs. This can lead to respiratory, sinus, and fertility problems. By analyzing multiple genes simultaneously using NGS (Next-Generation Sequencing) technology, we can identify mutations in the CCNO gene and confirm a diagnosis of primary ciliary dyskinesia.

Test Details

Test Name: CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A19

Why Choose NGS Testing for Primary Ciliary Dyskinesia?

NGS testing is a powerful tool that allows us to analyze multiple genes simultaneously. In the case of primary ciliary dyskinesia, NGS can be used to identify mutations in the CCNO gene, among others, to confirm a diagnosis. This type of genetic testing can provide valuable information for treatment and management options.

If you suspect primary ciliary dyskinesia or have a family history of the condition, it is recommended to consult with a genetic counselor or a healthcare professional experienced in genetic testing. They can help determine if NGS testing, including CCNO gene analysis, is appropriate for you or your family member.

At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. Our team of experts is here to support you throughout the testing process and provide you with the information you need for better treatment and management of primary ciliary dyskinesia.

Test Name CCNO Gene Primary ciliary dyskinesia type 29 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A19
Test Details

CCNO gene, also known as cyclin O, is associated with a rare genetic disorder called primary ciliary dyskinesia type 29. Primary ciliary dyskinesia (PCD) is a heterogeneous group of genetic disorders characterized by impaired function of cilia in various organs, leading to respiratory, sinus, and fertility problems.

NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to analyze multiple genes simultaneously. In the case of primary ciliary dyskinesia, NGS can be used to identify mutations in the CCNO gene, among others, to confirm a diagnosis. This type of genetic testing can help identify the specific genetic variant causing the disorder and provide valuable information for treatment and management options.

If you suspect primary ciliary dyskinesia or have a family history of the condition, consulting with a genetic counselor or a healthcare professional experienced in genetic testing can help determine if NGS testing, including CCNO gene analysis, is appropriate for you or your family member.